Medicine
Silvadene 1% cream
Silvadene 1% cream is a prescription medicine containing Silver sulfadiazine for topical use, marketed by Pfizer Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at Controlled Room Temperature 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Silver sulfadiazine
- Brand
- Silvadene
- Strength
- 1%
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube, 400 g, 50 g and 5 more
- Marketing authorisation holder
- Pfizer Laboratories
- Manufacturers
- Pfizer LaboratoriesA-S Medication Solutions
- Origin register
- US FDA, United States
- Storage
- Store at Controlled Room Temperature 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- D06BA01 Silver sulfadiazine
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 November 1973
- Identifiers
- RxCUI 106351, 208186DailyMed set ID 54b77a36-205b-4044-9ecb-c5130f0934b5, c437213a-1cd4-445e-a39f-bbcacb9f746fNDC 50090-0230, 61570-131Application NDA017381
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 20 g in 1 tube | 61570-131-20 | Pfizer Laboratories | 26 November 1973 |
| 1 tube in 1 carton / 25 g in 1 tube | 61570-131-25 | Pfizer Laboratories | 26 May 2015 |
| 400 g in 1 jar | 61570-131-40 | Pfizer Laboratories | 26 November 1973 |
| 50 g in 1 jar | 61570-131-50 | Pfizer Laboratories | 26 November 1973 |
| 1 tube in 1 carton / 50 g in 1 tube | 61570-131-55 | Pfizer Laboratories | 26 May 2015 |
| 1 tube in 1 carton / 85 g in 1 tube | 61570-131-85 | Pfizer Laboratories | 26 November 1973 |
| 1000 g in 1 jar | 61570-131-98 | Pfizer Laboratories | 26 November 1973 |
| 1 tube in 1 carton / 20 g in 1 tube | 50090-0230-0 | A-S Medication Solutions | 29 June 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 26 November 1973 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Silver sulfadiazine 1% cream.
- Silver sulfadiazine 1% creamAvailable on request—US FDA31 packs
- SSD Cream 1% creamAvailable on requestDr. Reddy's LaboratoriesIndiaUS FDA9 packs
- Thermazene Silver Sulfadiazine 1% creamAvailable on requestPreferred PharmaceuticalsUS FDA3 packs
- Ssd 1% creamAvailable on requestA-S Medication SolutionsUS FDA1 pack
Clinical summary
Silver sulfadiazine is a sulfonamide antibacterial indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns. It is available as cream for topical use. MedsAcross supplies Silver sulfadiazine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Silver sulfadiazineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SILVADENE prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
Need Silvadene 1% cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.